CGHS – Ceiling rates for Cardiac Pacemaker, AICD, Combo-device, Rotablator and Aortic Stent Graft
CGHS – Revision of ceiling rates for reimbursement of the cost of Cardiac pacemaker , AICD, Combo-device, Rotablator & Aortic Stent Graft
Government of India
Ministry of Health and Family Welfare
Department of Health & Family Welfare
Directorate Genera! of CGHS
Office of the Director, CGHS
No: S-11011/29/2018-CGHS(HEC)/ DIR/CGHS
Nirman Bhawan, New Delhi
Dated the 6th August, 2018
OFFICE MEMORANDUM
Subject:- Revision of ceiling rates for reimbursement of the cost of Cardiac pacemaker, AICD, Combo-device, Rotablator and Aortic Stent Graft for beneficiaries of CGHS/CS(MA) Rules
With reference to the above subject attention is drawn to the OM No 12034/02/2014/Misc./CGHS D.III dated 22nd July 2014 vide which ceiling rates for reimbursement of the cost of Cardiac pacemaker, AICD, Combo-device, Rotablator and Aortic Stent Graft for beneficiaries of CGHS/CS (MA) Rules were prescribed and to state that the matter has been reviewed by the Ministry and it is decided to revise the ceiling rates as per the details given under:
| SI. NO. | CARDIAC DEVICE | CEILING RATE |
|---|---|---|
| 1 | Single Chamber Cardiac Pacemaker without Rate Response | Rs. 34,840/- + GST |
| 2 | Single Chamber Cardiac Pacemaker with Rate Response | Rs. 44.928/-+ GST |
| 3 | Dual Chamber Cardiac Pacemaker | Rs.83,200/-+ GST |
| 4 | Bi-Ventricular Cardiac Pacemaker | Rs.1,95,000/-+ GST |
| 5 | Implantable Cardioverter Defibrillator (Single Chamber)(ICD/AICD-Single Chamber) | Rs.1,75.786/-+ GST |
| 6 | Implantable Cardioverter Defibrillator (Dual Chamber)(ICD/AICD-Single Chamber) | Rs. 3,75,000/-+ GST |
| 7 | Combo Device (CRT-D) | Rs. 4,90,000/-+ GST |
| 8 | Aortic Stent Graft (expandable, bifurcated and including delivery system) | Rs. 4,40,960/- + GST |
| 9 | Rotablator with Advancer | Rs.49,920/-+ GST |
| 10 | Rotablator Burr | Rs.23,920/-+ GST |
- Other terms and conditions prescribed under OM No 12034/02/2014/Misc./-CGHS D.III dated 22nd July 2014 shall remain unchanged.
- These rates shall remain valid till the rates for the above devices are notified by National Pharmaceutical Pricing Authority (NPPA).
- issued with the concurrence of SS&FA, Ministry of Health & Family Welfare vide CD — 1295 dated 25.07.2018.
Dr. Atul Prakash)
Director, CGHS
📢 Stay Updated with GConnect
Join our Whatsapp channels for the latest news and job updates:
Join GConnect News Join GConnect Jobs
GConnect News
GConnect Jobs
Join our Telegram channels for the latest news and job updates:
Join GConnect News Join GConnect Jobs
GConnect News
GConnect Jobs